EVOLUTION BIO
LIVE

Serial Number

98848881

Owner

Evolution Bio, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Nov 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EVOLUTION BIO Trademark

Serial Number: 98848881

EVOLUTION BIO is a trademark filed by Evolution Bio, Inc. on November 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Evolution Bio, Inc.

1090 Center Drive
Park City, UT 84098

Entity Type: 03

Trademark Details

Filing Date

November 12, 2024

Registration Date

Not Registered

Published for Opposition

July 1, 2025

Goods & Services

Protein engineering services, namely, the recombination of genes customized to the specification of others to produce novel gene sequences for use in science, research, and medicine

Development of pharmaceutical preparations and medicines; research and development in the biotechnology field; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; research and development of pharmaceutical preparations and substances for use in clinical trials; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drugs, materials, and molecular development; software as a service (saas) services featuring computer software platforms for use in optimizing drugs, materials, and molecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drugs, materials, and molecular discovery

Mixed biological preparations for the prevention and treatment of infectious diseases; therapeutic pharmaceuticals for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, as well as cancer and transplant rejections

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2026 EXRA
SOU EXTENSION 1 GRANTED
Feb 26, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 26, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 26, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 26, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 21, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2024 NWOS
NEW APPLICATION ENTERED
Nov 12, 2024 NWAP